A grant from the National Institutes of Health (NIH) was awarded to Emory University School of Medicine and Children's Healthcare of Atlanta to find new ways to make kidney transplants more tolerable for children. Currently, anti-rejection drugs are adapted for children by weight, but the immune system does not grow in parallel with a child's weight. This causes the child to be over-immunosuppressed.
 
Emory and Children's Healthcare are partnering with UCLA's Mattel Children's Hospital in Los Angeles and Lucile Packard Children's Hospital at Stanford in Palo Alto. This allows the study to encompass a large variety of demographic groups and nationalities.

This article originally appeared in the April 2008 issue of Kidney Transplant Today.